Your new company
An established global biopharmaceutical company with expertise in neuroscience. They are interested in expanding their scope of expertise through potential involvement with new assets or new companies, with a target focus on rare diseases.
Your new role
This is a high profile, visible role within the business where you will be responsible for making assessments on information based on potential involvement with new assets/companies and what that may look like. The interest of the CEO is to have a focus on rare disease assets/companies. You will be responsible for assessing both publicly available and proprietary information and presenting this information to the CEO and stakeholders.
An exciting position for someone who has a rare disease background and would like to offer insights and advice to a global business to expand their portfolio.
What you'll need to succeed
* Previous divestment experience
* Expertise with EU and the US markets (EMEA and FDA)
* Deep understanding of early and late stage development
* Experience handling sensitive information
* Strong communication skills and ability to present to key stakeholders
What you'll get in return
Fully remote role within the UK, 6-month initial contract with scope to extend.
What you need to do now
If you're interes...